Literature DB >> 1962089

Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia.

H Akiyama1, T Maruyama, T Uetake, K Kawaguchi, H Sakamaki, Y Onozawa.   

Abstract

Disseminated atypical mycobacterial infection has been reported mainly in patients with AIDS and hairy cell leukemia. We describe three patients with chronic myelogenous leukemia (CML) who developed disseminated atypical mycobacterial infection in the chronic stage of their disease. The incidence of the latter infection is 3.9% among patients with CML at our institution; such a high incidence has never before been reported. There are no specific signs or symptoms other than fever. The bone marrow is the culture site most often useful in diagnosis. An immunologic defect may be one of the features of CML. Clinicians must thus be aware of the possibility of disseminated atypical mycobacterial infection in patients with CML.

Entities:  

Mesh:

Year:  1991        PMID: 1962089     DOI: 10.1093/clinids/13.5.815

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  2 in total

1.  Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.

Authors:  S P Klemens; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

2.  Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.

Authors:  N A Giese; L Gabriele; T M Doherty; D M Klinman; L Tadesse-Heath; C Contursi; S L Epstein; H C Morse
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.